Scott Cotler, MD is a Professor of Medicine and Chief of the Division of Hepatology at Loyola. He has a busy clinical practice at sites throughout the state of Illinois. His research interests include modeling of viral hepatitis and studies of hepatocellular carcinoma. He is dedicated to teaching and mentoring.

I am a full time clinical Gastroenterologist/Hepatologist with Texas Digestive Specialists in South Texas. I am also involved in teaching as a clinical assistant professor at the University of Texas Rio Grande Valley. I have a strong interest in research and therapeutics in MASH which has become an epidemic in the community that I serve.

Dr. Balakrishnan is an Associate Professor of Medicine at Baylor College of Medicine in Houston, a physician-investigator, and staff gastroenterologist at Ben Taub Hospital. Her clinical practice spans the breath of general gastroenterology and hepatology. She is a clinical researcher from the NIH, her research program focuses on health behaviors and developing scalable, effective behavioral interventions for patients with chronic liver disease, with a special focus on medically underserved populations.

Dr. Bilal Hameed's is a Professor of Medicine at the University of California-San Francisco (UCSF). He is also the Ambulatory Chair of Hepatology at UCSF Medical Center and Director of Steatotic Liver Clinic.

Prof. Dr. Manuel Romero-Gómez. Director of UCM Digestive Diseases at Virgen del Rocío University Hospital. Full Professor of Medicine at Medical School, University of Seville. Head of SeLiver Group at Institute of Biomedicine of Seville (IBIS). PI at Ciberehd group 47/2006 ISCIII and CTS-532 research group in Andalucia. Director of Hepatic, Digestive and Inflammatory Diseases Translational Research Program at IBIS. External expert in Scientific Committee at IRyCIS, FPS, ISCIII, ANR, IHU-3, European Commission and NIH/NIDDK.

I am a pediatric transplant hepatologist at Lurie Children's Hospital in Chicago. I am the medical director for hepatology and liver transplant and the program director for our transplant hepatology fellowship program. My clinical and research interests are related to immune mechanisms of liver disease pre- and post-transplant including the pathophysiology of pediatric acute liver failure.

Dr. David E. Kaplan is an Professor of Medicine and Director of Hepatology at the Perelman School of Medicine at the University of Pennsylvania. He has held multiple committee leadership roles in the AASLD. He is an active clinician and mentor. Previous research focused on antigen-specific T-cell dysfunction in liver cancer and B-cell dysfunction related to cirrhosis, a key component of cirrhosis associated-immunodeficiency. His research currently focuses on outcomes and clinical research in cirrhosis, viral hepatitis, portal hypertension, and hepatocellular carcinoma.

Dr. Liya Pi is an Assistant Professor in Department of Pathology at Tulane University. Her study focuses on identifying profibrotic signals responsible for abnormal liver repair. By using the knowledge gained through these studies, her research team is investigating molecular pathogenesis of alcohol-associated liver disease and metabolic dysfunction-associated liver disease, and exploring novel therapeutic targets for the treatment of these maladies.

Katie Rude MD is an Associate Professor of Medicine at the University of Arkansas for Medical Sciences (UAMS). She serves as medical director of liver transplant at UAMS. Her interests include MASLD, alcohol-associated liver disease, and liver transplant. She completed her training at Washington University in St. Louis and University of Michigan prior to coming to UAMS.

Huiping Zhou, Ph.D/. AGAF, FAASLD, Assistant Dean for Research Faculty and Professor of the Department of Microbiology and Immunology, School of Medicine, Virginia Commonwealth University. Research Career Scientist of Richmond VA Medical Center.